Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
This study aims to understand, at a qualitative and quantitative level, immune response durability in 'real-life settings' of different vaccination regimens in individuals with a diagnosis of chronic lymphocytic leukaemia (CLL). To achieve this, we will track longitudinal immunity, analysing serum antibody titre and live virus neutralisation, both to wild-type and variant targets. In terms of T cell immunity, we will track durability of response and frequency to wild-type and variant epitopes using a range of approaches.
National Core Studies Programme (NCS) immunity